---
title: "ABEO: Q2 2026 net revenue rose 31% to $11.4M as ZEVASKYN expanded to seven QTCs and gained NTAP status"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295814699.md"
description: "ZEVASKYN's Q2 2026 rollout expanded to seven QTCs, treating 12 patients since launch, with $11.4M in net revenue and a 31% sequential increase. Operational learnings and NTAP status support future growth, while gross margins are expected to normalize at 85%-90% as volumes rise.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-13T14:28:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295814699.md)
  - [en](https://longbridge.com/en/news/295814699.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295814699.md)
generator: "portal-rs"
---

# ABEO: Q2 2026 net revenue rose 31% to $11.4M as ZEVASKYN expanded to seven QTCs and gained NTAP status

ZEVASKYN's Q2 2026 rollout expanded to seven QTCs, treating 12 patients since launch, with $11.4M in net revenue and a 31% sequential increase. Operational learnings and NTAP status support future growth, while gross margins are expected to normalize at 85%-90% as volumes rise.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [ABEO.US](https://longbridge.com/en/quote/ABEO.US.md)

## Related News & Research

- [ABEO: ZEVASKYN's launch accelerates with expanding access, strong coverage, and promising patient outcomes](https://longbridge.com/en/news/298466989.md)
- [ABEO Investors Have Opportunity to Join Abeona Therapeutics Inc. Fraud Investigation with SBS Law](https://longbridge.com/en/news/298396132.md)
- [NetApp (NTAP) Stock May Trade At A Cash Flow Discount But An Earnings Premium](https://longbridge.com/en/news/298459490.md)
- [FREEM: Expansion into manufacturing services targets a 20x larger market and EBITDA positivity by 2028](https://longbridge.com/en/news/298413697.md)
- [WELL Health names Evelyn Sutherland CFO, Eva Fong shifts to executive advisor role](https://longbridge.com/en/news/298436441.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**